Literature DB >> 25089632

Reactive oxygen species adversely impacts bone marrow microenvironment in diabetes.

Giuseppe Mangialardi1, Gaia Spinetti, Carlotta Reni, Paolo Madeddu.   

Abstract

UNLABELLED: Significance: Patients with diabetes mellitus suffer an excess of cardiovascular complications and recover worse from them as compared with their nondiabetic peers. It is well known that microangiopathy is the cause of renal damage, blindness, and heart attacks in patients with diabetes. This review highlights molecular deficits in stem cells and a supporting microenvironment, which can be traced back to oxidative stress and ultimately reduce stem cells therapeutic potential in diabetic patients. RECENT ADVANCES: New research has shown that increased oxidative stress contributes to inducing microangiopathy in bone marrow (BM), the tissue contained inside the bones and the main source of stem cells. These precious cells not only replace old blood cells but also exert an important reparative function after acute injuries and heart attacks. CRITICAL ISSUES: The starvation of BM as a consequence of microangiopathy can lead to a less efficient healing in diabetic patients with ischemic complications. Furthermore, stem cells from a patient's BM are the most used in regenerative medicine trials to mend hearts damaged by heart attacks. FUTURE DIRECTIONS: A deeper understanding of redox signaling in BM stem cells will lead to new modalities for preserving local and systemic homeostasis and to more effective treatments of diabetic cardiovascular complications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25089632      PMCID: PMC4175424          DOI: 10.1089/ars.2014.5944

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  123 in total

Review 1.  Stem cell heterogeneity: implications for aging and regenerative medicine.

Authors:  Christa E Muller-Sieburg; Hans B Sieburg; Jeff M Bernitz; Giulio Cattarossi
Journal:  Blood       Date:  2012-03-09       Impact factor: 22.113

2.  AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species.

Authors:  Marisa M Juntilla; Vineet D Patil; Marco Calamito; Rohan P Joshi; Morris J Birnbaum; Gary A Koretzky
Journal:  Blood       Date:  2010-03-30       Impact factor: 22.113

3.  FOXO transcription factors enforce cell cycle checkpoints and promote survival of hematopoietic cells after DNA damage.

Authors:  Hong Lei; Frederick W Quelle
Journal:  Mol Cancer Res       Date:  2009-08-11       Impact factor: 5.852

4.  HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes.

Authors:  Birgit Assmus; Carmen Urbich; Alexandra Aicher; Wolf K Hofmann; Judith Haendeler; Lothar Rössig; Ioakim Spyridopoulos; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circ Res       Date:  2003-04-03       Impact factor: 17.367

5.  Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.

Authors:  Gian Paolo Fadini; Marta Miorin; Monica Facco; Sondra Bonamico; Ilenia Baesso; Franco Grego; Mirko Menegolo; Saula Vigili de Kreutzenberg; Antonio Tiengo; Carlo Agostini; Angelo Avogaro
Journal:  J Am Coll Cardiol       Date:  2005-05-03       Impact factor: 24.094

6.  miR-155 regulates HGAL expression and increases lymphoma cell motility.

Authors:  Liat Nadav Dagan; Xiaoyu Jiang; Shruti Bhatt; Elena Cubedo; Klaus Rajewsky; Izidore S Lossos
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

7.  Stem cell defects in ATM-deficient undifferentiated spermatogonia through DNA damage-induced cell-cycle arrest.

Authors:  Keiyo Takubo; Masako Ohmura; Masaki Azuma; Go Nagamatsu; Wakako Yamada; Fumio Arai; Atsushi Hirao; Toshio Suda
Journal:  Cell Stem Cell       Date:  2008-02-07       Impact factor: 24.633

8.  Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy.

Authors:  J Lin; A Bierhaus; P Bugert; N Dietrich; Y Feng; F Vom Hagen; P Nawroth; M Brownlee; H-P Hammes
Journal:  Diabetologia       Date:  2006-03-07       Impact factor: 10.122

9.  Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus.

Authors:  Elena De Falco; Daniele Avitabile; Pierangela Totta; Stefania Straino; Francesco Spallotta; Chiara Cencioni; Anna Rita Torella; Roberto Rizzi; Daniele Porcelli; Antonella Zacheo; Luca Di Vito; Giulio Pompilio; Monica Napolitano; Guido Melillo; Maurizio C Capogrossi; Maurizio Pesce
Journal:  J Cell Mol Med       Date:  2009-09       Impact factor: 5.310

10.  New epigenetic pathway for stemness maintenance mediated by the histone methyltransferase Ezh1.

Authors:  Isabel Hidalgo; Susana Gonzalez
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

View more
  10 in total

1.  Dyslipidemia Is a Major Factor in Stem Cell Damage Induced by Uncontrolled Long-Term Type 2 Diabetes and Obesity in the Rat, as Suggested by the Effects on Stem Cell Culture.

Authors:  Maryam Masouminia; Robert Gelfand; Istvan Kovanecz; Dolores Vernet; James Tsao; Ruben Salas; Kenny Castro; Leila Loni; Jacob Rajfer; Nestor F Gonzalez-Cadavid
Journal:  J Sex Med       Date:  2018-12       Impact factor: 3.802

Review 2.  The bone marrow pericyte: an orchestrator of vascular niche.

Authors:  Giuseppe Mangialardi; Andrea Cordaro; Paolo Madeddu
Journal:  Regen Med       Date:  2016-11-25       Impact factor: 3.806

3.  Reduction of Endoplasmic Reticulum Stress Improves Angiogenic Progenitor Cell function in a Mouse Model of Type 1 Diabetes.

Authors:  Maulasri Bhatta; Krishna Chatpar; Zihua Hu; Joshua J Wang; Sarah X Zhang
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

4.  Advancements in Free-Radical Pathologies and an Important Treatment Solution with a Free-Radical Inhibitor.

Authors:  R C Petersen; M S Reddy; P-R Liu
Journal:  SF J Biotechnol Biomed Eng       Date:  2018-02-21

5.  Bone marrow pericyte dysfunction in individuals with type 2 diabetes.

Authors:  Giuseppe Mangialardi; David Ferland-McCollough; Davide Maselli; Marianna Santopaolo; Andrea Cordaro; Gaia Spinetti; Maria Sambataro; Niall Sullivan; Ashley Blom; Paolo Madeddu
Journal:  Diabetologia       Date:  2019-04-17       Impact factor: 10.122

6.  Circulating Pro-Vascular Progenitor Cell Depletion During Type 2 Diabetes: Translational Insights Into the Prevention of Ischemic Complications in Diabetes.

Authors:  Daniella C Terenzi; Mohammed Al-Omran; Adrian Quan; Hwee Teoh; Subodh Verma; David A Hess
Journal:  JACC Basic Transl Sci       Date:  2018-11-05

7.  Impairment of type H vessels by NOX2-mediated endothelial oxidative stress: critical mechanisms and therapeutic targets for bone fragility in streptozotocin-induced type 1 diabetic mice.

Authors:  Xiao-Fan Hu; Geng Xiang; Tian-Ji Wang; Yu-Bo Ma; Yang Zhang; Ya-Bo Yan; Xiong Zhao; Zi-Xiang Wu; Ya-Fei Feng; Wei Lei
Journal:  Theranostics       Date:  2021-01-30       Impact factor: 11.556

Review 8.  Understanding Reactive Oxygen Species in Bone Regeneration: A Glance at Potential Therapeutics and Bioengineering Applications.

Authors:  Aaron J Sheppard; Ann Marie Barfield; Shane Barton; Yufeng Dong
Journal:  Front Bioeng Biotechnol       Date:  2022-02-07

Review 9.  Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic Complications.

Authors:  Giuseppe Mangialardi; Paolo Madeddu
Journal:  Curr Diab Rep       Date:  2016-05       Impact factor: 4.810

Review 10.  Inside out: Bone marrow adipose tissue as a source of circulating adiponectin.

Authors:  Erica L Scheller; Aaron A Burr; Ormond A MacDougald; William P Cawthorn
Journal:  Adipocyte       Date:  2016-03-22       Impact factor: 4.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.